Iteos Therapeutics Inc (ITOS) — Capital Reinvestment Ratio
Latest as of December 2024:
0.03x
Iteos Therapeutics Inc (ITOS) has a Capital Reinvestment Ratio of 0.03x as of December 2024, meaning it reinvests 0% of its operating cash flow ($5.50 Million) in capital expenditures ($152.00K). See Iteos Therapeutics Inc (ITOS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
$5.50 Million
USD
Capital Expenditures
$152.00K
USD
Data as of
Dec 2024
Most recent filing
Iteos Therapeutics Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Iteos Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Iteos Therapeutics Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Iteos Therapeutics Inc from 2021 to 2021. For live market cap and broader valuation context, see ITOS market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $513.14 Million | $1.18 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow